Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors

Key facts

Sponsor

Memorial Sloan Kettering Cancer Center

Principal Investigator

Robert J. Motzer, MD

Memorial Sloan Kettering Cancer Center

Intervention

bleomycin sulfate(biological)

Enrollment

270 enrolled

Eligibility

12 years · MALE

Timeline

1994 – 2006

Study locations (30)

• Northeast Alabama Regional Medical Center, Anniston, Alabama, United States
• Arizona Cancer Center, Tucson, Arizona, United States
• University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
• City of Hope Comprehensive Cancer Center, Duarte, California, United States
• Sutter Health Western Division Cancer Research Group, Greenbrae, California, United States
• Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States
• USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
• Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
• Chao Family Comprehensive Cancer Center, Orange, California, United States
• St. Joseph Hospital - Orange, Orange, California, United States
• Sutter Cancer Center, Sacramento, California, United States
• University of California Davis Cancer Center, Sacramento, California, United States
• Veterans Affairs Medical Center - San Diego, San Diego, California, United States
• UCSF Comprehensive Cancer Center, San Francisco, California, United States
• Veterans Affairs Medical Center - San Francisco, San Francisco, California, United States
• +15 more locations on ClinicalTrials.gov

Collaborators

National Cancer Institute (NCI) · Eastern Cooperative Oncology Group · SWOG Cancer Research Network · Cancer and Leukemia Group B

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Extragonadal germ cell tumor

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT06418789
  High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors
  N.N. Petrov National Medical Research Center of Oncology
• RECRUITINGPHASE3NCT03067181
  Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
  Children's Oncology Group
• ACTIVE NOT RECRUITINGPHASE3NCT02375204
  Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors
  Alliance for Clinical Trials in Oncology

See all trials for Extragonadal germ cell tumor →